CompanyDRUGNasdaqChicago, IL

Bright Minds Biosciences Inc.

Bright Minds develops selective serotonergic agonists for neurological and psychiatric disorders including epilepsy, Prader-Willi Syndrome, and depression.

Stories only

SEC EDGAR ClinicalTrials.gov sedarplus.ca

6-KOct 1Latest SEC filing, period to Sep 30

Sep 30Latest story

September 2026

Bright Minds Biosciences to join FPWR symposium and PWS family conference in October 2026

Sep 30PublicationBright Minds Biosciences Inc.